Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3,5-Diaminobenzonitrile, with the chemical formula C7H7N3, is a white to light brown crystalline powder. It is a chemical compound primarily utilized in the production of dyes and pigments, as well as serving as an intermediate in the synthesis of pharmaceuticals and other organic compounds. Due to its potential as a skin and eye irritant, careful control of exposure and adherence to safety precautions are essential when handling this chemical in industrial and laboratory settings.

33786-93-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 33786-93-5 Structure
  • Basic information

    1. Product Name: 3,5-DIAMINOBENZONITRILE
    2. Synonyms: 3,5-Diaminobenzonitrile 97%
    3. CAS NO:33786-93-5
    4. Molecular Formula: C7H7N3
    5. Molecular Weight: 133.15
    6. EINECS: N/A
    7. Product Categories: C6 to C7;Cyanides/Nitriles;Nitrogen Compounds
    8. Mol File: 33786-93-5.mol
  • Chemical Properties

    1. Melting Point: 188-191 °C
    2. Boiling Point: 405.506°C at 760 mmHg
    3. Flash Point: 199.043°C
    4. Appearance: /
    5. Density: 1.245g/cm3
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.64
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3,5-DIAMINOBENZONITRILE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3,5-DIAMINOBENZONITRILE(33786-93-5)
    12. EPA Substance Registry System: 3,5-DIAMINOBENZONITRILE(33786-93-5)
  • Safety Data

    1. Hazard Codes: Xn
    2. Statements: 22
    3. Safety Statements: N/A
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 33786-93-5(Hazardous Substances Data)

33786-93-5 Usage

Uses

Used in Dye and Pigment Production:
3,5-Diaminobenzonitrile is used as a key intermediate in the synthesis of various dyes and pigments. Its unique chemical structure contributes to the color properties and stability of the final products, making it an important component in this industry.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 3,5-Diaminobenzonitrile serves as a crucial intermediate for the production of certain drugs. Its reactivity and functional groups make it a versatile building block in the synthesis of a range of pharmaceutical compounds.
Used in Organic Compound Synthesis:
3,5-Diaminobenzonitrile is also utilized as an intermediate in the synthesis of other organic compounds. Its presence in various chemical reactions allows for the creation of a wide array of products, highlighting its importance in organic chemistry.
Safety Precautions:
Given its potential to cause skin and eye irritation, it is imperative to handle 3,5-Diaminobenzonitrile with care. Proper protective equipment, such as gloves and safety goggles, should be worn during its use. Additionally, it is essential to follow established safety protocols and guidelines to minimize potential hazards in both industrial and laboratory settings.

Check Digit Verification of cas no

The CAS Registry Mumber 33786-93-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,7,8 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 33786-93:
(7*3)+(6*3)+(5*7)+(4*8)+(3*6)+(2*9)+(1*3)=145
145 % 10 = 5
So 33786-93-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H7N3/c8-4-5-1-6(9)3-7(10)2-5/h1-3H,9-10H2

33786-93-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-Diaminobenzonitrile

1.2 Other means of identification

Product number -
Other names Benzonitrile,3,5-diamino

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33786-93-5 SDS

33786-93-5Relevant articles and documents

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

Paragraph 00343, (2020/07/14)

Provided herein are piperidine dione compounds having the following structure (I) wherein RN, R1, R2, R3, R4, L,V, m, and n are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.

SUBSTITUTED 3-((3-AMINOPHENYL)AMINO)PIPERIDINE-2,6-DIONE COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

Paragraph 0544; 0548, (2020/07/14)

Provided herein are piperidine dione compounds having the following structure: wherein RN, R1, R2, R3, R4, X, L, V, m, and n are as defined herein, compositions comprising an effective amount of a piperidine dione compound, and methods for treating or preventing an androgen receptor mediated disease.

Corresponding amine nitrile and method of manufacturing thereof

-

, (2018/05/07)

The invention relates to a manufacturing method of nitrile. Compared with the prior art, the manufacturing method has the characteristics of significantly reduced using amount of an ammonia source, low environmental pressure, low energy consumption, low production cost, high purity and yield of a nitrile product and the like, and nitrile with a more complex structure can be obtained. The invention also relates to a method for manufacturing corresponding amine from nitrile.

7-CHLORO-QUINOLIN-4-AMINE COMPOUNDS AND USES THEREOF FOR THE PREVENTION OR TREATMENT OF DISEASES INVOLVING FORMATION OF AMYLOID PLAQUES AND/OR WHERE A DYSFUNCTION OF THE APP METABOLISM OCCURS

-

Page/Page column 41, (2011/07/07)

The present invention relates to compounds having the following Formula (I) for use in the prevention and/or the treatment of diseases involving formation of amyloid plaques and/or where a dysfunction of the APP metabolism occurs.

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

-

Page/Page column 101, (2009/05/29)

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants

-

Page/Page column 55, (2010/11/25)

The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, Y, Z, R7, R8, R9, and R11 are as defined herein. These compounds are selective inhibitors of factor VIIa which can be used as medicaments.

NOVEL AMIDE COMPOUNDS

-

, (2008/06/13)

A compound of the formula (I):R1-A-X-NHCO-Y-R2 ???whereinR1 is heterocyclic group which may have suitable substituents, or phenyl which may have suitable substituents,R2 is condensed phenyl which may have suitable substituents, phenyl which may have suitable substituents, or thienyl which may have suitable substituents,A is a group of the formula:-(CH2)t-(O)m- or in which R3 and R4 are each hydrogen or linked together to form imino,R5 is hydrogen or lower alkyl,t is 0, 1 or 2,p, m and n are each 0 or 1,X is phenylene which may have suitable substituents, or bivalent heterocyclic group containing nitrogen which may have suitable substituents,Y is bond, lower alkylene, or lower alkenylene, and a salt thereof.

Anxiolytic activity of analogues of 4-benzylamino-2-methyl-7H- pyrrolo[2,3-d]pyrimidines

Meade, Eric A.,Sznaidman, Marcos,Pollard, Gerald T.,Beauchamp, Lilia M.,Howard, James L.

, p. 363 - 374 (2007/10/03)

An extensive series of analogues of the lead anxiolytic 4-benzylamino- 2-methylpyrrolo[2,3-d]pyrimidine 1 was synthesized and evaluated in the Geller-Seifter conflict test for anxiolytic activity to discover a less toxic derivative. Analysis of the SAR revealed that the most potent compounds were those with meta substituents on the benzylamino ring. In this group the most promising derivatives were 4-[bis(3,5-dimethylamino)]benzylamino-2-methyl- 7H-pyrrolo[2,3-d]pyrimidine 12 and 4-(3,5-dimethylbenzylamino)-2-methyl-7H- pyrrolo[2,3-d]pyrimidine 24. Potential metabolites of 12 were synthesized and checked for their anxiolytic activity. Less toxic analogues of the second lead 24 were prepared by extending the alkyl groups attached to the benzene ring moiety. The addition of a fluoro substituent to the benzene moiety in the extended alkyl chain analogue 4-(3,5-diethyl-2-fluorobenzylamino)2- methyl-7H-pyrrolo[2,3-d]pyrimidine 34 resulted in a compound with a longer duration of activity relative to its analogue 4-(3,5-diethylbenzylamino)-2- methyl-7H-pyrrolo[2,3-d]pyrimidine 26.

Cyano phenylene dioxamic molecules

-

, (2008/06/13)

Compounds represented below SPC1 And pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 33786-93-5